| Biotechnology Industry | Healthcare Sector | Dr. Bin Pan Li CEO | SSE Exchange | CNE000001DD2 ISIN |
| CN Country | 463 Employees | 5 Jan 2006 Last Dividend | 7 Jun 2006 Last Split | 27 Dec 2002 IPO Date |
Beihai Gofar Chuanshan Biological Co., Ltd., previously known as Beihai Gofar Marine Biological Industry Co., Ltd., is a prominent player in the Chinese pharmaceutical industry, specializing in the production and distribution of pharmaceutical products. Recognized for its remarkable Haibao brand, the company has carved a niche in the market since its establishment in 1993. Headquartered in Beihai, China, it underwent a significant rebranding in May 2021, changing its name to better reflect its broadening scope in biological products. The company is not just restricted to manufacturing but also extends its services to medical imaging, tumor therapy, and advanced diagnostic services, showcasing its commendable journey towards becoming a comprehensive healthcare entity in China.
Beihai Gofar Chuanshan Biological Co., Ltd. offers an extensive range of pharmaceutical solutions, from traditional medications to advanced medical services:
Beyond their product line, Beihai Gofar Chuanshan Biological Co., Ltd. also advances in medical services: